Issue Date | Title | Involved Person(s) |
2023 | Biosimilars helfen sparen | Grobet, Cécile; Mattli, Renato; Wieser, Simon |
2022 | The value of prevention : a health economics perspective | Marti, Joachim; Mattli, Renato; Nicolet, Anna; Wieser, Simon |
2022 | Health technology assessment (HTA) : medicines for dementia due to Alzheimer's and Parkinson's disease | Mattli, R.; Tomonaga, Y.; Tzogiou, C.; Vinci, L.; Sharakin, M.; Wirth, B.; Carlander, M.; Schliek, M.; Egli, Ph.; Gerber-Grote, A.; Nordström, K.; Wieser, S. |
2022 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis | Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda; Syleouni, Maria-Eleni; Carlander, Maria; Meier, Flurina; Egli, Philipp; Gerber-Grote, Andreas; Wieser, Simon |
2020 | The burden of smoking in Switzerland : estimation for 2015 and prognosis until 2050 | Mattli, Renato; Farcher, Renato; Dettling, Marcel; Syleouni, Maria-Eleni; Wieser, Simon |
2014 | Gesellschaftliche Kosten der körperlichen Inaktivität in der Schweiz | Mattli, Renato; Hess, Sascha; Maurer, Matthias; Eichler, Klaus; Pletscher, Mark; Wieser, Simon |
2013 | Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland | Mattli, Renato; Eichler, Klaus; Pletscher, Mark; Wieser, Simon |